These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 19029444

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL-mediated leukemia.
    Nakamura A, Masuya M, Shinmei M, Tawara I, Nosaka T, Ono R.
    Blood Adv; 2024 May 14; 8(9):2193-2206. PubMed ID: 38452334
    [Abstract] [Full Text] [Related]

  • 26. MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.
    Wang QF, Wu G, Mi S, He F, Wu J, Dong J, Luo RT, Mattison R, Kaberlein JJ, Prabhakar S, Ji H, Thirman MJ.
    Blood; 2011 Jun 23; 117(25):6895-905. PubMed ID: 21518926
    [Abstract] [Full Text] [Related]

  • 27. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia.
    Chen L, Sun Y, Wang J, Jiang H, Muntean AG.
    Oncotarget; 2016 May 03; 7(18):25208-23. PubMed ID: 27007052
    [Abstract] [Full Text] [Related]

  • 28. The PHD fingers of MLL block MLL fusion protein-mediated transformation.
    Muntean AG, Giannola D, Udager AM, Hess JL.
    Blood; 2008 Dec 01; 112(12):4690-3. PubMed ID: 18796627
    [Abstract] [Full Text] [Related]

  • 29. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
    Luo RT, Lavau C, Du C, Simone F, Polak PE, Kawamata S, Thirman MJ.
    Mol Cell Biol; 2001 Aug 01; 21(16):5678-87. PubMed ID: 11463848
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia.
    Röhrs S, Dirks WG, Meyer C, Marschalek R, Scherr M, Slany R, Wallace A, Drexler HG, Quentmeier H.
    Mol Cancer; 2009 Oct 16; 8():86. PubMed ID: 19835597
    [Abstract] [Full Text] [Related]

  • 32. Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C.
    Schwieger M, Schüler A, Forster M, Engelmann A, Arnold MA, Delwel R, Valk PJ, Löhler J, Slany RK, Olson EN, Stocking C.
    Blood; 2009 Sep 17; 114(12):2476-88. PubMed ID: 19584403
    [Abstract] [Full Text] [Related]

  • 33. Analysis of acute leukemias with MLL/ENL fusion transcripts: identification of two novel breakpoints in ENL.
    Fu JF, Liang DC, Shih LY.
    Am J Clin Pathol; 2007 Jan 17; 127(1):24-30. PubMed ID: 17145626
    [Abstract] [Full Text] [Related]

  • 34. Molecular findings in childhood leukemia in Brazil: high frequency of MLL-ENL Fusion/t(11;19) in infant leukemia.
    Marques EA, Neves L, Fonseca TC, Lins MM, Pedrosa F, Lucena-Silva N.
    J Pediatr Hematol Oncol; 2011 Aug 17; 33(6):470-4. PubMed ID: 21436736
    [Abstract] [Full Text] [Related]

  • 35. Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF.
    Nishimoto N, Arai S, Ichikawa M, Nakagawa M, Goyama S, Kumano K, Takahashi T, Kamikubo Y, Imai Y, Kurokawa M.
    Blood; 2011 Sep 01; 118(9):2541-50. PubMed ID: 21757616
    [Abstract] [Full Text] [Related]

  • 36. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
    Germano G, Morello G, Aveic S, Pinazza M, Minuzzo S, Frasson C, Persano L, Bonvini P, Viola G, Bresolin S, Tregnago C, Paganin M, Pigazzi M, Indraccolo S, Basso G.
    Oncotarget; 2017 Apr 18; 8(16):26129-26141. PubMed ID: 28412727
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
    Wang H, Bei L, Shah CA, Huang W, Platanias LC, Eklund EA.
    Oncogene; 2018 May 18; 37(19):2532-2544. PubMed ID: 29459712
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.
    Baker A, Gregory GP, Verbrugge I, Kats L, Hilton JJ, Vidacs E, Lee EM, Lock RB, Zuber J, Shortt J, Johnstone RW.
    Cancer Res; 2016 Mar 01; 76(5):1158-69. PubMed ID: 26627013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.